Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 0.26%193.39K | -61.71%370.62K | -92.32%148.49K | -90.76%223.23K | -90.76%223.23K | -74.20%192.89K | -63.23%967.83K | 83.02%1.93M | 27.50%2.42M | 27.50%2.42M |
| -Cash and cash equivalents | 0.26%193.39K | -61.71%370.62K | -92.32%148.49K | -90.76%223.23K | -90.76%223.23K | -74.20%192.89K | -63.23%967.83K | 83.02%1.93M | 27.50%2.42M | 27.50%2.42M |
| Receivables | -73.07%36.31K | -64.81%102.9K | 57.12%361.51K | -8.59%454.23K | -8.59%454.23K | -87.53%134.82K | 66.36%292.39K | 87.59%230.09K | -56.27%496.89K | -56.27%496.89K |
| -Accounts receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 87.59%230.09K | ---- | ---- |
| -Taxes receivable | -73.07%36.31K | -64.39%104.12K | --312.74K | -18.65%404.23K | -18.65%404.23K | --134.82K | --292.39K | ---- | -56.27%496.89K | -56.27%496.89K |
| -Other receivables | ---- | ---1.22K | --48.78K | --50K | --50K | ---- | ---- | ---- | ---- | ---- |
| Prepaid assets | -32.76%15.64K | -59.11%13.76K | -57.42%17.63K | -32.28%17.01K | -32.28%17.01K | 20.26%23.25K | 31.23%33.64K | -42.49%41.4K | -56.94%25.12K | -56.94%25.12K |
| Total current assets | -30.10%245.33K | -62.34%487.28K | -76.08%527.63K | -76.36%694.47K | -76.36%694.47K | -81.01%350.96K | -54.34%1.29M | 76.25%2.21M | -4.91%2.94M | -4.91%2.94M |
| Non current assets | ||||||||||
| Net PPE | ---- | ---- | ---- | --0 | --0 | -38.93%121.74K | -35.48%141.14K | -32.59%160.54K | -30.86%179.94K | -30.86%179.94K |
| -Gross PPE | ---- | ---- | ---- | --0 | --0 | 0.00%283.03K | 0.00%283.03K | 0.00%283.03K | 6.81%283.03K | 6.81%283.03K |
| -Accumulated depreciation | ---- | ---- | ---- | --0 | --0 | -92.72%-161.29K | -120.70%-141.89K | -172.86%-122.49K | -2,083.23%-103.09K | -2,083.23%-103.09K |
| Total non current assets | --0 | --0 | --0 | --0 | --0 | -38.93%121.74K | -35.48%141.14K | -32.59%160.54K | -30.86%179.94K | -30.86%179.94K |
| Total assets | -48.10%245.33K | -66.04%487.28K | -77.71%527.63K | -77.72%694.47K | -77.72%694.47K | -76.91%472.7K | -52.99%1.44M | 58.86%2.37M | -6.92%3.12M | -6.92%3.12M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Current debt and capital lease obligation | ---- | ---- | ---- | ---- | ---- | 9.38%53.06K | 9.38%51.88K | 9.38%50.73K | 9.38%49.61K | 9.38%49.61K |
| -Current capital lease obligation | ---- | ---- | ---- | --0 | --0 | 9.38%53.06K | 9.38%51.88K | 9.38%50.73K | 9.38%49.61K | 9.38%49.61K |
| Payables | -18.34%167.13K | -66.33%185.21K | -25.72%138.49K | -39.19%101.26K | -39.19%101.26K | -42.30%204.67K | 5.80%550.14K | -62.46%186.45K | -77.32%166.51K | -77.32%166.51K |
| -accounts payable | -18.34%167.13K | -66.33%185.21K | -25.72%138.49K | -39.19%101.26K | -39.19%101.26K | -42.30%204.67K | 5.80%550.14K | -62.46%186.45K | -77.32%166.51K | -77.32%166.51K |
| Current accrued expenses | -7.01%54.63K | 68.31%54.7K | 86.31%38.45K | 7.19%65K | 7.19%65K | -19.39%58.75K | -79.56%32.5K | -86.79%20.64K | -63.91%60.64K | -63.91%60.64K |
| Other current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --4.85K | --4.85K |
| Current liabilities | -29.93%221.76K | -62.19%239.91K | -31.37%176.94K | -40.96%166.26K | -40.96%166.26K | -36.50%316.48K | -18.89%634.53K | -63.13%257.82K | -70.28%281.6K | -70.28%281.6K |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | ---- | ---- | ---- | ---- | ---- | -52.50%48K | -45.67%61.71K | -40.31%75.12K | -35.99%88.23K | -35.99%88.23K |
| -Long term capital lease obligation | ---- | ---- | ---- | --0 | --0 | -52.50%48K | -45.67%61.71K | -40.31%75.12K | -35.99%88.23K | -35.99%88.23K |
| Total non current liabilities | -100.00%1 | --0 | --0 | --0 | --0 | -52.50%48K | -45.67%61.71K | -40.31%75.12K | -35.99%88.23K | -35.99%88.23K |
| Total liabilities | -39.16%221.76K | -65.54%239.91K | -46.86%176.94K | -55.05%166.26K | -55.05%166.26K | -39.20%364.47K | -22.29%696.24K | -59.65%332.94K | -65.92%369.84K | -65.92%369.84K |
| Shareholders'equity | ||||||||||
| Share capital | 1.04%30.86M | 1.03%30.86M | 0.54%30.69M | 0.54%30.69M | 0.54%30.69M | 3.82%30.54M | 6.73%30.54M | 18.20%30.52M | 18.20%30.52M | 18.20%30.52M |
| -common stock | 1.04%30.86M | 1.03%30.86M | 0.54%30.69M | 0.54%30.69M | 0.54%30.69M | 3.82%30.54M | 6.73%30.54M | 18.20%30.52M | 18.20%30.52M | 18.20%30.52M |
| Additional paid-in capital | 2.44%1.78M | 5.41%1.77M | 8.50%1.76M | 10.12%1.73M | 10.12%1.73M | -66.40%1.73M | -66.02%1.68M | -66.30%1.62M | 10.08%1.57M | 10.08%1.57M |
| Retained earnings | -0.27%-33.23M | -0.73%-33.05M | -5.61%-33.2M | -7.56%-33M | -7.56%-33M | 4.05%-33.14M | 0.19%-32.81M | -1.10%-31.43M | -17.44%-30.67M | -17.44%-30.67M |
| Other equity interest | -36.24%620.02K | -49.62%668.15K | -16.75%1.1M | -16.75%1.1M | -16.75%1.1M | -31.06%972.37K | -9.93%1.33M | 17.35%1.33M | 17.35%1.33M | 17.35%1.33M |
| Total stockholders'equity | -78.22%23.57K | -66.52%247.37K | -82.76%350.69K | -80.78%528.21K | -80.78%528.21K | -92.53%108.22K | -65.74%738.76K | 205.99%2.03M | 21.36%2.75M | 21.36%2.75M |
| Total equity | -78.22%23.57K | -66.52%247.37K | -82.76%350.69K | -80.78%528.21K | -80.78%528.21K | -92.53%108.22K | -65.74%738.76K | 205.99%2.03M | 21.36%2.75M | 21.36%2.75M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.